{
    "nct_id": "NCT05722288",
    "official_title": "A Randomized, Phase II Clinical Trial of Time-Restricted Eating Versus Nutritional Counseling in Cancer Patients Receiving Radiation or Chemoradiation to Evaluate Its Impact on Toxicity and Efficacy",
    "inclusion_criteria": "* Male and female patients aged 18 or older\n* Localized high risk prostate cancer or node positive prostate cancer histologically confirmed by biopsy or recurrence after surgical resection planning to receive whole pelvis radiation therapy +/- androgen deprivation therapy or\n* Locally advanced cervical cancer receiving whole pelvic/paraaortic radiation therapy + concurrent cisplatin-based chemotherapy or\n* Locally advanced rectal cancer receiving whole pelvis radiation therapy + concurrent 5FU/capecitabine\n* Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2\n* Able to provide a written consent for study participation\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* PROSTATE CANCER: Prior radiation therapy to the prostate gland or pelvis\n* PROSTATE CANCER: Prior therapy with androgen deprivation therapy for longer than 6 months\n* PROSTATE CANCER: Prior chemotherapy\n* PROSTATE CANCER: Men with diabetes may enroll, provided they are on stable doses of antihyperglycemic medication for at least 6 months and provided the physician managing their diabetes feels they can safely hold antihyperglycemic medication during daily time-restricted eating\n* PROSTATE CANCER: Must be eligible to receive neoadjuvant and concurrent androgen deprivation therapy, but androgen deprivation therapy is not required\n* PROSTATE CANCER: Men whose treatment plan includes up-front docetaxel will be excluded due potential confounding\n* PROSTATE CANCER: Patients whose body mass index (BMI) is less than 21 at time of screening\n* PROSTATE CANCER: Men who are currently undergoing a strict macronutrient or time limited diet including ketogenic, low-carbohydrate (carb), paleolithic (paleo), or warrior diet are excluded\n* GYNECOLOGIC CANCER: Prior radiation therapy to the cervix, uterus or pelvis\n* GYNECOLOGIC CANCER: Prior chemotherapy\n* GYNECOLOGIC CANCER: Women must not be pregnant, planning to become pregnant or lactating at the time of enrollment or during the course of the study\n* GYNECOLOGIC CANCER: Women with diabetes may enroll, provided they are on stable doses of antihyperglycemic medication for at least 6 months and provided the physician managing their diabetes feels they can safely hold antihyperglycemic medication during daily time-restricted eating\n* GYNECOLOGIC CANCER: Must be eligible to receive chemotherapy that is cisplatin based\n* GYNECOLOGIC CANCER: Patients whose BMI is less than 21 at time of screening\n* GYNECOLOGIC CANCER: Women who are currently undergoing a strict macronutrient or time limited diet including ketogenic, low-carb, paleo, or warrior diet are excluded\n* RECTAL CANCER: Prior pelvic radiation therapy\n* RECTAL CANCER: Prior chemotherapy\n* RECTAL CANCER: Patients with diabetes may enroll, provided they are on stable doses of antihyperglycemic medication for at least 6 months and provided the physician managing their diabetes feels they can safely hold antihyperglycemic medication during daily time-restricted eating\n* RECTAL CANCER: Patients whose BMI is less than 21at time of screening\n* RECTAL CANCER: Women must not be pregnant, planning to become pregnant or lactating at the time of enrollment or during the course of the study\n* RECTAL CANCER: Patients who are currently undergoing a strict macronutrient or time limited diet including ketogenic, low-carb, paleo, or warrior diet are excluded",
    "miscellaneous_criteria": ""
}